NCT01625481View on ClinicalTrials.gov

Seal-V Safety and Performance Study

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2014

Conditions
C.Surgical Procedure; Vascular (Peripheral)
Interventions
DEVICE

Seal-V

Seal-V is applied adjunctively to cover the suture lines.

Trial Locations (3)

52621

Department of Vascular Surgery, Chaim Sheba Medical Center, Tel Litwinsky

Unknown

Department of Vascular Surgery, Bnai-Zion Medical Center, Haifa

Vascular Surgery Department, Rambam Health Care, Haifa

All Listed Sponsors
lead

Sealantis Ltd.

INDUSTRY

NCT01625481 - Seal-V Safety and Performance Study | Biotech Hunter | Biotech Hunter